KPNA2 and hepatocellular carcinoma: Further, eight genes (<i>TMEM106C</i>, <i>BSG</i>, <i>COPE</i>, <i>CDCA8</i>, <i>KPNA2</i>, <i>LIG1</i>, <i>UQCRH</i>, and <i>CCT5</i>) with differential expression in HCC were applied to construct the risk model, which could stratify HCC patients into different risks and predict the prognosis.